Navigation Links
China Kanghui Holdings Announces Participation in Upcoming Investor Conferences
Date:10/27/2011

CHANGZHOU, China, Oct. 27, 2011 /PRNewswire-Asia/ -- China Kanghui Holdings (NYSE: KH) ("Kanghui" or the "Company"), a leading domestic developer, manufacturer and marketer of orthopedic implants in China, today announced its participation in the following investor events:

  • Bank of America Merrill Lynch New China Conference to be held on October 31 - November 4, 2011 at the JW Marriot Hotel in Beijing, China.  Management is scheduled to meet with institutional investors on November 2, 2011.
  • CLSA AsiaUSA Forum to be held on November 7 - 9, 2011 at the Palace Hotel in San Francisco.  Management is scheduled to present on November 7, 2011 at 11.30 a.m. and meet with institutional investors throughout the day.
  • Cowen China Opportunity Inaugural Conference to be held on November 15 - 16, 2011 at the St. Regis Hotel in Beijing, China.  Management is scheduled to present on November 15, 2011 at 9 a.m. and meet with institutional investors throughout the day.
  • Lazard Capital Markets 8th Annual Healthcare Conference to be held on November 15 - 16, 2011 at the Pierre Hotel in New York City.  Management is scheduled to present on November 15, 2011 at 8.30 a.m. and meet with institutional investors throughout the day.
  • Morgan Stanley Asia Pacific Summit to be held on November 16 - 17, 2011 at Mandarin Oriental Hotel in Singapore.  Management is scheduled to meet with institutional investors throughout the 2 days.
  • Piper Jaffray 23rd Annual Healthcare Conference to be held on November 29 - 30, 2011 at the New York Palace Hotel in New York City. Management is scheduled to present on November 30, 2011 at 3 p.m. and meet with institutional investors throughout the day.
  • Oppenheimer & Co. 22nd Annual Healthcare Conference to be held on December 13 - 14, 2011 at the Waldorf Astoria Hotel in New York City.  Management is scheduled to present on December 13, 2011 at 8.50 a.m. and meet with institutional investors throughout the day.

About China Kanghui Holdings

Founded in 1997, Kanghui is a leading domestic developer, manufacturer and marketer of orthopedic implants in China. The Company offers a wide array of proprietary orthopedic implant products in trauma and spine. It has an extensive network of distributors for its products in China. In addition, Kanghui's products are distributed in 28 countries. Kanghui has strong research and development capabilities, focused on developing new proprietary products, including new product lines, extensions of existing product lines and enhancements of existing products. For more information, please visit www.kanghui.com.

Contact:
China Kanghui Holdings Investor Relations Department  
+1-888-321-2558

Asia Bridge Capital Limited
Carene Toh
+86-186 1835 6339
carene.toh@asiabridgegroup.com


'/>"/>
SOURCE China Kanghui Holdings
Copyright©2010 PR Newswire.
All rights reserved

Related medicine technology :

1. HUYA Bioscience Intl Announces Clinical Trial Milestones in China for Promising New Anti-Arrhythmic Compound; Data Supports Desirable Safety Profile
2. HUYA Bioscience Intl Announces World-Class Clinical Advisory Team for New Anti-Arrhythmic Compound Sourced From China
3. HUYA Bioscience Intl Announces First Pre-IND Outcome for a Development Stage Compound Sourced From China - HBI-8000, Promising New Cancer Compound
4. HUYA Bioscience Intl Announces Pre-IND Outcome for HBI-3000 - Promising Anti-Arrhythmia Compound Sourced From China
5. China Sky One Medical, Inc. Announces 26 New Drugs in Clinical Trials
6. RHEI Pharmaceuticals Announces the Initiation of the Final Clinical Study for Approval of Tibozole in China
7. Varian Medical Systems to Exhibit Cancer Treatment and X-ray Imaging Technologies at China Med Exhibition
8. China Sky One Medical, Inc. Achieves Significant Breakthrough in Research for Sudden Cardiac Death (SCD) Early Examination Kit
9. China Animal Welfare Law Under Review While 36,000 Dogs Culled
10. China-Biotics, Inc. Prices $69 Million Public Offering of Common Stock
11. Clifford Chance Advises Pfizer on Conditional Clearance in China of Its Merger with Wyeth
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:6/23/2016)... Capricor Therapeutics, Inc. ... company focused on the discovery, development and commercialization ... in its ongoing randomized HOPE-Duchenne clinical trial (Halt ... its 24-patient target. Capricor expects the trial to ... 2016, and to report top line data from ...
(Date:6/23/2016)... 2016  Astellas today announced the establishment of Astellas Farma Colombia (AFC), a new affiliate with operations headquartered in ... America . ... ... ... ...
(Date:6/23/2016)... 2016  Experian Health, the healthcare industry ... patient payment and care experience, today announced ... and services that will enhance the breadth ... These award-winning solutions will enable healthcare professionals ... in an ever-changing environment and redefine front-office ...
Breaking Medicine Technology:
(Date:6/25/2016)... ... June 25, 2016 , ... Austin residents seeking Mohs ... College of Mohs Surgery and to Dr. Russell Peckham for medical and surgical dermatology. ... treatment for skin cancer. The selective fellowship in Mohs Micrographic Surgery completed by Dr. ...
(Date:6/25/2016)... City, Oklahoma (PRWEB) , ... June 25, 2016 ... ... helping both athletes and non-athletes recover from injury. Recently, he has implemented orthobiologic ... the Oklahoma City area —Johnson is one of the first doctors to perform ...
(Date:6/24/2016)... ... June 24, 2016 , ... June 19, 2016 is World Sickle Cell Observance ... and the benefits of holistic treatments, Serenity Recovery Center of Marne, Michigan, ... Disease. , Sickle Cell Disease (SCD) is a disorder of the red blood cells, ...
(Date:6/24/2016)... ... June 24, 2016 , ... Comfort Keepers® of San Diego, ... and the Road To Recovery® program to drive cancer patients to and from their ... to ensure the highest quality of life and ongoing independence. Getting to and ...
(Date:6/24/2016)... Las Vegas, Nevada (PRWEB) , ... June 24, ... ... their Las Vegas client, The Grove Investment Group (TGIG), has initiated cultivation and ... The Grove, in Las Vegas and Pahrump, Nevada. , Puradigm is the manufacturer ...
Breaking Medicine News(10 mins):